Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
Recruiting now
Conditions studied: Long Term Follow-up
In brief
This is a long term follow-up study for chronic hepatitis B (CHB) subjects who have received imdusiran treatment in a prior clinical trial, stopped NA therapy during that trial, and remain off therapy. Subjects may enroll after completing the end of study visit (baseline visit within 12 weeks ± 1 week from the end of study \[EOS\] visit) from their imdusiran clinical trial (the "parent study"). No interventions will be performed in this study other than blood sample collections, review of current medications, and reporting of any adverse events related to study procedures or NA therapy if restarted. Study participation will be for approximately 2 years (to complete a total of at least 3 years of follow-up while off NA therapy, inclusive of parent study participation).
Key facts
- Study ID
- NCT06277037
- Run by
- Arbutus Biopharma Corporation
- People needed
- 50
- Starts
- 2024-07-11
- Expected to finish
- 2029-10-30
- Last updated by the study team
- 2024-11-27
Who can join
Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Not applicable
Where it is running
- Research and Education Inc. — San Diego, California, United States (enrolling)
- Changhua Christian Hospital — Changhua, Taiwan (enrolling)
- Chia-Yi Christian Hospital — Chiayi City, Taiwan (enrolling)
- Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City, Taiwan (enrolling)
- E-Da Hospital — Kaohsiung City, Taiwan (enrolling)
- Taichung Veterans General Hospital — Taichung, Taiwan (enrolling)
- Chang Gung Medical Foundation Linkou — Taoyuan, Taiwan (enrolling)
- Infectious Disease Care — Hillsborough, New Jersey, United States (enrolling)
- The Alfred Hospital — Melbourne, Victoria, Australia (enrolling)
- Prince of Wales Hospital — Shatin, New Territories, Hong Kong (enrolling)
- Queen Mary Hospital — Hong Kong, Hong Kong (enrolling)
- Arensia Exploratory Medicine Moldova — Chisinau, Moldova (enrolling)
- University of Miami Miller School of Medicine — Miami, Florida, United States
- King's College Hospital — London, United Kingdom
- Asan Medial Center — Seoul, South Korea
- Fiona Stanley Hospital — Murdoch, Australia
- University Hospital of Wales, Cardiff — Cardiff, United Kingdom
- Royal London Hospital — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.